ABSTRACT
Background: Breast cancer is the most common cancer in women and the second cause of death after lung cancer. One in eight women will become ill during their lifetime. Deaths from breast cancer made up around 7.2% of all deaths from cancer while among women, breast cancer accounted for 16.2% of all deaths from cancer. To assess anxiety, depression in women with breast cancer undergoing radiotherapy.Material & Methods:The study was conducted in the Department of Clinical Oncology, Enam Medical College & Hospital from March 2020 to April 2021. A total number of 120 women diagnosed with non-metastatic breast cancer were recruited for this cross-sectional survey. Following informed consent, patients were asked to complete demographics and clinical data questionnaire comprising with, the Dass-21 scale, the Hospital Anxiety and Depression Scale- HADS. Data was analyzed using IBM SPSS software system.Results:The incidence of depression and anxiety for breast cancer patients is high. Results highlight similar prevalence of depression with HADS (37.5% mild and moderate depression and 62.5% serious depression) DASS-21 (39.2% mild and moderate 60.8% serious depression) but not similar for anxiety.Conclusions:The psychological complication in breast cancer patients was remarkable. Efforts to detect and treat depression and anxiety should be a priority, since they contribute to better tolerance and effectiveness in anti-neoplasmatic therapies.